Oseltamivir Phosphate Powder, For Suspension
Product Images NDC 64380-879

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 64380-879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (77e8e587 76ff 4587 862a A700565c0bc6 01)

Structural Formula (77e8e587 76ff 4587 862a A700565c0bc6 01)
Chemical structure diagram of oseltamivir phosphate, showing its molecular components and arrangement including the cyclohexene ring, amino group, ester side chain, and phosphate group.*
FDA Label Image

Bottle Carton (77e8e587 76ff 4587 862a A700565c0bc6 02)

Bottle Carton (77e8e587 76ff 4587 862a A700565c0bc6 02)
Packaging label for Oseltamivir Phosphate for Oral Suspension 6 mg/mL powder, for suspension, oral use. The product is supplied in a 60 mL usable volume bottle after constitution. Labeler is Strides Pharma Science Limited. The label includes dosing instructions, storage, and preparation notes, with barcodes and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.